Last reviewed · How we verify
Hyperlipoproteinemia
Approved treatments
- Olbemox
Olbemox works by activating the hydroxycarboxylic acid receptor 2, which helps to reduce the production of triglycerides in the liver. - Olbetam · University of Aarhus
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hyperlipoproteinemia patent landscape — cliff calendar, originator estates, attackable patents
- Hyperlipoproteinemia treatment landscape brief
- Hyperlipoproteinemia treatment updates RSS
Frequently asked questions about Hyperlipoproteinemia
What drugs treat Hyperlipoproteinemia?
Tracked treatments include Olbemox, Olbetam.
What is the treatment for Hyperlipoproteinemia?
Standard treatment for Hyperlipoproteinemia includes Olbemox, Olbetam. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hyperlipoproteinemia patent cliff · Hyperlipoproteinemia CI report
- Treatment: Olbemox
- Treatment: Olbetam · University of Aarhus
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing